Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Tamia Nguyen
Characterization of a Novel Venetoclax Resistance Mutation (BCL2 Phe104Ile) Observed in Follicular Lymphoma
British Journal of Haematology
Hematology
Related publications
The BCL2 Inhibitor Venetoclax Is Active in Non-Hodgkin Lymphoma
Cancer Discovery
Oncology
Targeting BCL2 With Venetoclax Is a Promising Therapeutic Strategy for "Double-Protein-Expression" Lymphoma With MYC and BCL2 Rearrangements
Haematologica
Hematology
Phase Ib/Ii Study of Ibrutinib and Venetoclax in Relapsed and Refractory Follicular Lymphoma
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Metabolism and Disposition of a Novel B-Cell Lymphoma-2 Inhibitor Venetoclax in Humans and Characterization of Its Unusual Metabolites
Drug Metabolism and Disposition
Pharmacology
Pharmaceutical Science
Sakk 35/15: A Phase I Trial of Obinutuzumab in Combination With Venetoclax in Previously Untreated Follicular Lymphoma Patients
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Follicular Lymphoma
Nature Reviews Disease Primers
Medicine
Characterization of Intratumoral Follicular Helper T Cells in Follicular Lymphoma: Role in the Survival of Malignant B Cells
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
Follicular Large Cleaved Cell (Centrocytic) Lymphoma: A Distinctive but Unrecognized Variant of Follicular Lymphoma
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Unraveling Tumor Heterogeneity in an Apparently Monolithic Disease: BCL2 and Other Players in the Genetic Landscape of Nodal Follicular Lymphoma
Frontiers in Medicine
Medicine